RU98111594A - PHARMACEUTICAL COMPOSITIONS INCLUDING FLURBIPROFEN - Google Patents

PHARMACEUTICAL COMPOSITIONS INCLUDING FLURBIPROFEN

Info

Publication number
RU98111594A
RU98111594A RU98111594/14A RU98111594A RU98111594A RU 98111594 A RU98111594 A RU 98111594A RU 98111594/14 A RU98111594/14 A RU 98111594/14A RU 98111594 A RU98111594 A RU 98111594A RU 98111594 A RU98111594 A RU 98111594A
Authority
RU
Russia
Prior art keywords
flurbiprofen
throat
sore throat
chewed
therapeutically effective
Prior art date
Application number
RU98111594/14A
Other languages
Russian (ru)
Other versions
RU2203655C2 (en
Inventor
Майкл Барретт Дэвид
Симон Смит Карл
Майкл Тургуд Дэвид
Original Assignee
Дзе Бутс Компани ПЛС
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9523833.3A external-priority patent/GB9523833D0/en
Application filed by Дзе Бутс Компани ПЛС filed Critical Дзе Бутс Компани ПЛС
Publication of RU98111594A publication Critical patent/RU98111594A/en
Application granted granted Critical
Publication of RU2203655C2 publication Critical patent/RU2203655C2/en

Links

Claims (5)

1. Применение флурбипрофена для получения лекарственного препарата в виде твердой лекарственной формы, которую можно разжевывать или рассасывать, или спрея, предназначенного для высвобождения терапевтически эффективного количества флурбипрофена в полости рта таким образом, чтобы доставлять флурбипрофен на поверхность горла для лечения больного горла.1. The use of flurbiprofen to obtain a drug in the form of a solid dosage form that can be chewed or dissolved, or a spray designed to release a therapeutically effective amount of flurbiprofen in the oral cavity so as to deliver flurbiprofen to the throat surface for treating a sore throat. 2. Применение флурбипрофена для лечения заболеваний горла, которое включает введение пациенту, нуждающемуся в таком лечении, фармацевтической композиции в виде твердой лекарственной формы, которая может разжевываться или рассасываться, или спрея, содержащей терапевтически эффективное количество флурбипрофена и высвобождающей флурбипрофен в полость рта так, чтобы доставлять флурбипрофен на поверхность больного горла. 2. The use of flurbiprofen for the treatment of throat diseases, which comprises administering to a patient in need of such treatment a pharmaceutical composition in the form of a solid dosage form that can be chewed or dissolved, or a spray containing a therapeutically effective amount of flurbiprofen and releasing flurbiprofen into the oral cavity so that deliver flurbiprofen to the surface of a sore throat. 3. Способ лечения больного горла, включающий введение терапевтически эффективного количества флурбипрофена на поверхность больного горла из фармацевтической композиции в виде твердой лекарственной формы, которая может разжевываться или рассасываться, или спрея. 3. A method of treating a sore throat, comprising administering a therapeutically effective amount of flurbiprofen to the surface of a sore throat from a pharmaceutical composition in the form of a solid dosage form that can be chewed or absorbed, or spray. 4. Применение или способ, по любому из предыдущих пп., где количество флурбипрофена составляет 2,5 - 20 мг на стандартную лекарственную дозу. 4. The use or method, according to any one of the preceding paragraphs., Where the amount of flurbiprofen is 2.5 to 20 mg per standard dosage dose. 5. Применение или способ по п.4, где количество флурбипрофена составляет 5 - 12,5 мг на стандартную лекарственную дозу. 5. The use or method according to claim 4, where the amount of flurbiprofen is 5 to 12.5 mg per standard dosage dose.
RU98111594/14A 1995-11-22 1996-11-21 Agent and method for relieve of sick throat symptoms RU2203655C2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9523833.3 1995-11-22
GBGB9523833.3A GB9523833D0 (en) 1995-11-22 1995-11-22 Medical treatment

Publications (2)

Publication Number Publication Date
RU98111594A true RU98111594A (en) 2000-05-20
RU2203655C2 RU2203655C2 (en) 2003-05-10

Family

ID=10784245

Family Applications (1)

Application Number Title Priority Date Filing Date
RU98111594/14A RU2203655C2 (en) 1995-11-22 1996-11-21 Agent and method for relieve of sick throat symptoms

Country Status (21)

Country Link
US (2) US5889057A (en)
EP (1) EP0862424B1 (en)
CN (1) CN1148177C (en)
AT (1) ATE252382T1 (en)
AU (1) AU707749B2 (en)
BG (1) BG64166B1 (en)
CA (1) CA2238271C (en)
CZ (1) CZ289643B6 (en)
DE (1) DE69630460T2 (en)
DK (1) DK0862424T3 (en)
ES (1) ES2208768T3 (en)
GB (1) GB9523833D0 (en)
HU (1) HU225235B1 (en)
IL (1) IL124568A0 (en)
NO (1) NO317287B1 (en)
NZ (1) NZ322933A (en)
PT (1) PT862424E (en)
RU (1) RU2203655C2 (en)
SK (1) SK284092B6 (en)
UA (1) UA46807C2 (en)
WO (1) WO1997018802A1 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
AU8107998A (en) * 1997-05-22 1998-12-11 Boots Company Plc, The Pharmaceutical compositions
AU7916798A (en) * 1997-05-22 1998-12-11 Boots Company Plc, The Pharmaceutical compositions of flurbiprofen and burn-masking agent for treating sore throat
GB9710521D0 (en) * 1997-05-22 1997-07-16 Boots Co Plc Process
EP1206283A2 (en) * 1999-05-17 2002-05-22 Aesgen, Inc. Improved cellular uptake of bioactive agents
CA2406383A1 (en) * 2000-04-13 2001-10-25 Mayo Foundation For Medical Education And Research A.beta.42 lowering agents
CN1615135A (en) * 2001-11-13 2005-05-11 法马西亚公司 Oral dosage form of a sulfonamide prodrug such as parecoxib
US20090035260A1 (en) * 2002-07-29 2009-02-05 Therapicon Srl Enhanced nasal composition of active peptide
CN1802152A (en) * 2002-08-01 2006-07-12 艾斯根公司 Improved treatment of cancer with glutamine
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc Method and composition for treating neurodegenerative disorders
US20040265359A1 (en) * 2003-04-17 2004-12-30 Sacks Gordon S. Oral delivery formulations of L-glutamine
US20050042284A1 (en) * 2003-07-11 2005-02-24 Myriad Genetics, Incorporated Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
FR2865648B1 (en) * 2004-02-03 2006-06-30 Philippe Perovitch METHOD FOR DIFFUSION OF INSOLUBLE MOLECULES IN AQUEOUS MEDIUM AND COMPOSITION IMPLEMENTING SAID METHOD
ITMI20040235A1 (en) * 2004-02-13 2004-05-13 Therapicon Srl PHARMACEUTICAL PREPARATION FOR THE ORAL CABLE
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
CN1946906A (en) * 2004-04-29 2007-04-11 吉斯通护岸系统股份有限公司 Veneers for walls, retaining walls and the like
CA2618985A1 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
GB2423710A (en) * 2005-03-01 2006-09-06 Boots Healthcare Int Ltd Lozenge production process
CA2615063A1 (en) * 2005-07-22 2007-02-01 Myriad Genetics, Inc. High drug load formulations and dosage forms
KR20080034166A (en) * 2005-11-02 2008-04-18 테이코쿠 팔마 유에스에이, 인코포레이티드 Organoleptically acceptable ibuprofen oral dosage formulations, methods of making and using the same
US7282224B1 (en) * 2006-06-09 2007-10-16 Guthy-Renker Corporation Pain relief composition
EP2046119A2 (en) * 2006-07-07 2009-04-15 Myriad Genetics, Inc. Treatment of psychiatric disorders
US7754234B2 (en) * 2006-07-12 2010-07-13 Jones Thomas L Composition and method of treating a sore throat
US20080107747A1 (en) * 2006-10-23 2008-05-08 Roederer Joy E Pain relief composition
US20090028802A1 (en) * 2007-07-23 2009-01-29 Toru Hibi Organoleptically acceptable indole serotonin receptor agonist oral dosage formulations and methods of using the same
JP5643297B2 (en) 2009-05-19 2014-12-17 ニューロデルム リミテッド Composition for continuous administration of a dopa decarboxylase inhibitor
IT1397132B1 (en) 2009-12-01 2013-01-04 Alfa Wassermann Spa COMPOSITIONS INCLUDING NON-STEROID ANTI-INFLAMMATORS.
ES2660772T3 (en) * 2010-11-15 2018-03-26 Neuroderm Ltd Continuous administration of L-dopa, dopa decarboxylase inhibitors, catechol-o-methyl transferase inhibitors and compositions therefor
GB201021267D0 (en) * 2010-12-15 2011-01-26 Reckitt Benckiser Healthcare Int Ltd Novel pharmaceutical formulation
CN107693486A (en) 2012-06-05 2018-02-16 纽罗德姆有限公司 Composition comprising apomorphine and organic acid and application thereof
GB201216893D0 (en) 2012-09-21 2012-11-07 Aesica Pharmaceuticals Ltd Drug substance preparations, pharmaceutical compositions and dosage forms comprising s-(+)-flurbiprofen
EP3777833B1 (en) 2014-03-13 2023-10-18 Neuroderm Ltd. Dopa decarboxylase inhibitor compositions
US10258585B2 (en) 2014-03-13 2019-04-16 Neuroderm, Ltd. DOPA decarboxylase inhibitor compositions
CN110812331A (en) * 2018-08-10 2020-02-21 北京普德康利医药科技发展有限公司 Flurbiprofen pharyngeal retention particle
US11213502B1 (en) 2020-11-17 2022-01-04 Neuroderm, Ltd. Method for treatment of parkinson's disease
US11844754B2 (en) 2020-11-17 2023-12-19 Neuroderm, Ltd. Methods for treatment of Parkinson's disease
US11331293B1 (en) 2020-11-17 2022-05-17 Neuroderm, Ltd. Method for treatment of Parkinson's disease
CN115536525B (en) * 2022-09-23 2024-02-23 南京知和医药科技有限公司 S- (+) -flurbiprofen salt and preparation method, pharmaceutical composition and application thereof

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1062721A (en) * 1975-12-15 1979-09-18 Anthony A. Sinkula Propionic acid derivatives
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
JPH0647532B2 (en) * 1983-08-31 1994-06-22 ジ アツプジヨン カンパニ− Treatment of alveolar bone resorption
AU6656886A (en) * 1985-12-16 1987-06-18 Cilag A.G. Pharmaceutical composition of suprofen
WO1988003021A2 (en) * 1986-10-22 1988-05-05 The Upjohn Company Treatment of gingivitis with ibuprofen or flurbiprofen
JPS63156715A (en) * 1986-12-19 1988-06-29 Teisan Seiyaku Kk Quick-acting slowly releasing agent
JP2540581B2 (en) * 1988-02-04 1996-10-02 三省製薬株式会社 Topical
US4931473A (en) * 1989-02-15 1990-06-05 Richardson-Vicks Inc. Anesthetic oral compositions
US5190981A (en) * 1989-08-17 1993-03-02 Sepracor Inc. Formulation containing S(+) enantiomer of flurbiprofen or ketoprofen and method of use for oral administration for prevention and treatment of bone loss associated with periodontal disease
ATE117892T1 (en) * 1989-08-17 1995-02-15 Sepracor Inc ORAL S(+)-FLURBIPROFEN OR KETOPROFEN CONTAINING PRODUCT.
JP2738092B2 (en) * 1989-11-17 1998-04-08 ライオン株式会社 Oral composition
JPH0426618A (en) * 1990-05-21 1992-01-29 Japan Tobacco Inc Troche
IT1243342B (en) * 1990-07-13 1994-06-10 Farcon Ag ORAL PHARMACEUTICAL COMPOSITIONS FOR LIQUID ANTI-INFLAMMATORY ACTIVITIES
DE4028906A1 (en) * 1990-09-12 1992-03-19 Paz Arzneimittelentwicklung MEDICINAL PRODUCTS AND THEIR PREPARATION AND THEIR USE IN THE CONTROL OF PAIN AND / OR DEFENSE AND / OR FEVER OF ANIMALS AND PEOPLE
JPH07506839A (en) * 1992-12-04 1995-07-27 メイヤー・ファーマシューティカル・ラボラトリース・インコーポレーテッド Sprayable analgesic compositions and methods of use thereof
WO1994014476A1 (en) * 1992-12-21 1994-07-07 The Procter & Gamble Company Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders
US5458879A (en) * 1994-03-03 1995-10-17 The Procter & Gamble Company Oral vehicle compositions
ES2211916T3 (en) * 1994-09-02 2004-07-16 Virginia Commonwealth University COMPOSITION TO RELIEF PAIN, CONTAINING A NON-NARCORTIC ANALGESIC AND AN ANALGESIC POTENTIATOR.
US5567733B1 (en) * 1995-04-27 1999-08-24 Jon G Dishler Irritation relief using nonsteroidal anti-inflammatory compounds
EP0837862A1 (en) * 1995-07-05 1998-04-29 The Procter & Gamble Company Warming compounds
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
US5955098A (en) * 1996-04-12 1999-09-21 Flemington Pharmaceutical Corp. Buccal non polar spray or capsule
ATE288255T1 (en) * 1996-04-12 2005-02-15 Novadel Pharma Inc POLAR BUCCAL SPRAY

Similar Documents

Publication Publication Date Title
RU98111594A (en) PHARMACEUTICAL COMPOSITIONS INCLUDING FLURBIPROFEN
EP0862424B1 (en) Pharmaceutical compositions comprising flurbiprofen
ATE522211T1 (en) STABILIZED FIBRATE MICROPARTICLES
GB9401892D0 (en) Therapeutic agents
FI964593A (en) Oral liquid alendronate compositions
DE69027216D1 (en) TRANSMUCOSAL DOSAGE FORM
NZ508526A (en) Opioid formulations for treating pain
CA2240717A1 (en) Method of treating and diagnosing sleep disordered breathing and means for carrying out the method
SE8306367L (en) ANTIDIURETICALLY EFFECTIVE PHARMACEUTICAL PREPARATION
RU95101385A (en) Products containing g-csf and tnf-binding protein
US4387093A (en) Arthritis treatment
RU2007133435A (en) METHOD OF COMBINED TREATMENT AND APPLICABLE FOR THIS COMBINATION OF MEDICINES
RU93053489A (en) PHARMACEUTICAL COMPOSITION OF ANTI-ALCOHOLIC, STIMULATING ENERGY METABOLISM, ACID-FORMING AND SECRETARY FUNCTION OF THE Mucous Stomach, RADIO PROTECTIVE AND ANTI-CHEMOLAR
HK94096A (en) The use of certain calcium-citrate-malate for the manufacture of a medicament for the treatment of osteoporosis
IS4069A (en) Prolonged-release tablets containing Naproxen
RU99119233A (en) PHARMACEUTICAL COMPOSITIONS containing ibuprofen and domperidone for the treatment of migraine
ES2078251T3 (en) SYSTEM FOR THE REGULATED DISTRIBUTION OF ACTIVE AGENTS AND PROCESS FOR THEIR PREPARATION.
CA2350396A1 (en) A composition useful to treat periodontal disease
RU97120700A (en) NEW PHARMACOLOGICAL APPLICATION OF ANTAGONISTS A-II RECEPTOR
CA2368352A1 (en) Method for treating neurodegeneration
JP2000500159A (en) Painkillers combined with melatonin
KR830008678A (en) Analgesic composition
KR890001558A (en) Zephyron and its pharmaceutically acceptable acid addition salts alleviate panic disorder
PT95867A (en) Process for the preparation of a delayed-release composition comprising a lactide and glycolide copolymer, for treatment of periodontal diseases
SE8304818L (en) MEDICINE WITH ANTICULAR, SPASMOLYTIC AND LOCAL ANESTIC EFFECTS